These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1718 related articles for article (PubMed ID: 8299185)

  • 41. The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells.
    Girnita A; All-Ericsson C; Economou MA; Aström K; Axelson M; Seregard S; Larsson O; Girnita L
    Acta Ophthalmol; 2008 Nov; 86 Thesis 4():26-34. PubMed ID: 19032679
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TIA-1 positive tumor-infiltrating lymphocytes in nevi and melanomas.
    Lyle S; Salhany KE; Elder DE
    Mod Pathol; 2000 Jan; 13(1):52-5. PubMed ID: 10658910
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression and possible function of IL-2 and IL-15 receptors on human uveal melanoma cells.
    He YG; Mayhew E; Mellon J; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4240-6. PubMed ID: 15557426
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.
    Maat W; van der Slik AR; Verhoeven DH; Alizadeh BZ; Ly LV; Verduijn W; Luyten GP; Mulder A; van Hall T; Koning F; Jager MJ; van Bergen J
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2888-95. PubMed ID: 19234348
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cripto-1 expression in uveal melanoma: an immunohistochemical study.
    Mallikarjuna K; Vaijayanthi P; Krishnakumar S
    Exp Eye Res; 2007 Jun; 84(6):1060-6. PubMed ID: 17412323
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lymphocyte subpopulations before therapy in patients with uveal malignant melanoma.
    Flynn K; Felberg NT; Koegel A; Hager R; Shields JA; Augsburger JJ; Donoso LA
    Am J Ophthalmol; 1986 Feb; 101(2):160-3. PubMed ID: 3946530
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic parameters in uveal melanoma: a review.
    Mooy CM; De Jong PT
    Surv Ophthalmol; 1996; 41(3):215-28. PubMed ID: 8970236
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antigenic and cellular heterogeneity of primary uveal melanomas.
    Folberg R
    Arch Ophthalmol; 1986 Jun; 104(6):795, 798-9. PubMed ID: 3487304
    [No Abstract]   [Full Text] [Related]  

  • 49. Decreased expression of HLA class II antigens on human uveal melanoma cells after in vivo X-ray irradiation.
    Jager MJ; van der Pol JP; de Wolff-Rouendaal D; de Jong PT; Ruiter DJ
    Am J Ophthalmol; 1988 Jan; 105(1):78-86. PubMed ID: 3276205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Possibilities of the use of tumor immunity for the diagnosis and prognosis of malignant melanoma of uveal tissue].
    Cernák A; Kalafut F
    Cesk Oftalmol; 1983 May; 39(3):168-71. PubMed ID: 6347408
    [No Abstract]   [Full Text] [Related]  

  • 51. An antimelanoma monoclonal antibody and the histopathology of uveal melanomas.
    Folberg R; Donoso LA; Atkinson BF; Ernst CS; Herlyn M; Arbizo VV
    Arch Ophthalmol; 1985 Feb; 103(2):275-9. PubMed ID: 2579631
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cyclooxygenase-2 expression in uveal melanoma: novel classification of mixed-cell-type tumours.
    Figueiredo A; Caissie AL; Callejo SA; McLean IW; Gold P; Burnier MN
    Can J Ophthalmol; 2003 Aug; 38(5):352-6. PubMed ID: 12956275
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Melanomas of the uvea].
    Stipetić S; Talan-Hranilović J
    Lijec Vjesn; 1982 May; 104(5):181-3. PubMed ID: 7132547
    [No Abstract]   [Full Text] [Related]  

  • 54. Tumor-associated antibodies in the serum of patients with uveal melanoma.
    Brownstein S; Sheikh KM; Lewis MG
    Can J Ophthalmol; 1976 Apr; 11(2):147-54. PubMed ID: 1078333
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Immunological diagnosis of malignant melanomas of uveal tissue].
    Cernak A; Kalafut F; Hung PM
    Vestn Oftalmol; 1980; (5):60-3. PubMed ID: 7423736
    [No Abstract]   [Full Text] [Related]  

  • 56. A response to uveal melanoma: growth rate and prognosis.
    Woolson RF; Folberg R
    Arch Ophthalmol; 1998 Mar; 116(3):399-400. PubMed ID: 9514505
    [No Abstract]   [Full Text] [Related]  

  • 57. [Characteristics of autoimmune process in melanoma of the uveal tract].
    Linnik LF; Chabrova LS; Zarobelova ON
    Ross Med Zh; 1992; (3):29-31. PubMed ID: 1643355
    [No Abstract]   [Full Text] [Related]  

  • 58. [Nuclear inclusions in malignant melanoma of the uvea].
    Mincione GP; Campana G; Vannelli G; Graev A
    Arch De Vecchi Anat Patol; 1980; 64(1):75-85. PubMed ID: 6271078
    [No Abstract]   [Full Text] [Related]  

  • 59. Cytomorphometry of uveal melanomas: fine needle aspiration biopsy versus standard histology.
    Char DH; Kroll SM; Stoloff A; Crawford JB; Miller TR; Howes EL; Crawford P
    Trans Am Ophthalmol Soc; 1989; 87():197-210; discussion 210-2. PubMed ID: 2562521
    [No Abstract]   [Full Text] [Related]  

  • 60. Immunology of intraocular tumors.
    Niederkorn JY; Wang S
    Ocul Immunol Inflamm; 2005 Feb; 13(1):105-10. PubMed ID: 15835077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 86.